Literature DB >> 34773527

Key promoters of tumor hallmarks.

Keywan Mortezaee1, Jamal Majidpoor2.   

Abstract

Evolution of tumor hallmarks is a result of accommodation of tumor cells with their nearby milieu called tumor microenvironment (TME). Accommodation or adaptive responses is highly important for a cell to survive, without which no cell is allowed to take any further steps in tumorigenesis. Metabolism of cancer cells is largely depended on stroma. Composition and plasticity of cells within the stroma is highly affected from inflammatory setting of TME. Hypoxia which is a common event in many solid cancers, is known as one of the key hallmarks of chronic inflammation and the master regulator of metastasis. Transforming growth factor (TGF)-β is produced in the chronic inflammatory and chronic hypoxic settings, and it is considered as a cardinal factor for induction of all tumor hallmarks. Aging, obesity and smoking are the main predisposing factors of cancer, acting mainly through modulation of TME.
© 2021. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.

Entities:  

Keywords:  Cancer stem cell (CSC); Cancer-associated fibroblast (CAF); Extracellular matrix (ECM); Heterogeneity; Hypoxia; Inflammation; Obesity; Plasticity; Transforming growth factor (TGF); Tumor microenvironment (TME)

Mesh:

Year:  2021        PMID: 34773527     DOI: 10.1007/s10147-021-02074-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  120 in total

Review 1.  Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches.

Authors:  Nasser Hashemi Goradel; Nasir Mohajel; Ziba Veisi Malekshahi; Samira Jahangiri; Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Babak Negahdari; Arash Arashkia
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

Review 2.  The Gut-Brain Axis, Paving the Way to Brain Cancer.

Authors:  Ruty Mehrian-Shai; Juergen K V Reichardt; Curtis C Harris; Amos Toren
Journal:  Trends Cancer       Date:  2019-03-16

3.  The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review.

Authors:  Masoud Najafi; Mohammad Reza Hooshangi Shayesteh; Keywan Mortezaee; Bagher Farhood; Hamed Haghi-Aminjan
Journal:  Life Sci       Date:  2019-12-13       Impact factor: 5.037

Review 4.  Neutrophil Degranulation, Plasticity, and Cancer Metastasis.

Authors:  Faustino Mollinedo
Journal:  Trends Immunol       Date:  2019-02-15       Impact factor: 16.687

5.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

Review 6.  Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity.

Authors:  Alberto Mantovani; Charles A Dinarello; Martina Molgora; Cecilia Garlanda
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

Review 7.  Metabolic regulation of cell growth and proliferation.

Authors:  Jiajun Zhu; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

8.  Tumour hypoxia causes DNA hypermethylation by reducing TET activity.

Authors:  Bernard Thienpont; Jessica Steinbacher; Hui Zhao; Flora D'Anna; Anna Kuchnio; Athanasios Ploumakis; Bart Ghesquière; Laurien Van Dyck; Bram Boeckx; Luc Schoonjans; Els Hermans; Frederic Amant; Vessela N Kristensen; Kian Peng Koh; Massimiliano Mazzone; Mathew Coleman; Thomas Carell; Peter Carmeliet; Diether Lambrechts
Journal:  Nature       Date:  2016-08-17       Impact factor: 49.962

Review 9.  Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.

Authors:  Su Yeon Lee; Eui Kyong Jeong; Min Kyung Ju; Hyun Min Jeon; Min Young Kim; Cho Hee Kim; Hye Gyeong Park; Song Iy Han; Ho Sung Kang
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  8 in total

Review 1.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 2.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 3.  (Im)maturity in Tumor Ecosystem.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 4.  CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical Perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 5.  Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.

Authors:  Shweta Bisht; Manisha Nigam; Shyam S Kunjwal; Plygun Sergey; Abhay Prakash Mishra; Javad Sharifi-Rad
Journal:  Stem Cells Int       Date:  2022-06-28       Impact factor: 5.131

6.  m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.

Authors:  Zi-Jun Xu; Xiang-Mei Wen; Yuan-Cui Zhang; Ye Jin; Ji-Chun Ma; Yu Gu; Xin-Yi Chen; Pei-Hui Xia; Wei Qian; Jiang Lin; Jun Qian
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

Review 7.  Checkpoint inhibitor/interleukin-based combination therapy of cancer.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cancer Med       Date:  2022-03-17       Impact factor: 4.711

Review 8.  Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy.

Authors:  Wenhao Liao; Yuchen Li; Jing Wang; Maoyuan Zhao; Nianzhi Chen; Qiao Zheng; Lina Wan; Yu Mou; Jianyuan Tang; Zhilei Wang
Journal:  Int J Nanomedicine       Date:  2022-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.